In parallel, we assessed ANXA2 expression at the transcriptomic levels in human samples of primary and metastatic PCa using the dataset reported by Kumar et al. (GSE74685) [29] which involved 149 samples of metastasis (20 bone metastasis) and 22 primary tumor samples derived from 63 PCa patients. Here, ANXA2 is linked to posterior cortical atrophy.